Back to Clinical Trials
N/ARecruiting

Tracking Results of Ablations to Combat AF Registry Generation 2

Sponsored by AtriCure, Inc.

About this study

The primary objective of the TRAC-AF Registry is to capture real-world safety and effectiveness data on AtriCure devices used to conduct open concomitant and/or hybrid ablation, and management of the LAA concomitant to a cardiac ablation.

Up to 10,000 patients at up to 250 sites. Participating regions may include US, Canada, Europe, Asia Pacific and others to be determined. Registry participating sites will enroll patients that meet all inclusion criteria and no exclusion criteria without preselection or bias. Each patient will be followed for a period of up to ten (10) years after their procedure according to the standard practice at the enrolling center. There will be no additional visits, nor procedures, for subjects who participate in the registry.

Where this study is enrolling (24)

Show all 24 locations
Who can participate

Inclusion criteria

  • ✓1. Patient has been scheduled by physician(s) to undergo or has undergone cardiac ablation procedure(s)
  • ✓2. Patient is willing to provide informed consent
  • ✓3. Patient whose age is 18 years or above, or of legal age to give informed consent specific to state and national law

Exclusion criteria

  • ✕1\. Other medical, social, or psychological conditions that in the opinion of the Investigator precludes the subject from appropriate consent or adherence to the protocol.

Only the research team can confirm whether you qualify. The intake questionnaire is the best way to find out.

Completing a questionnaire on Clinably does not enroll you in a clinical trial or confirm your eligibility. Only the research team can determine whether you qualify to participate. These results are based on the information you provide and are intended to help you start a conversation with the research team.

Trial data sourced from ClinicalTrials.gov.